Global Generic Pharmaceuticals Market Poised for Robust Growth: Projected to Reach $916.2 Billion by 2033 with Strong Gains in Asia-Pacific and Emerging MarketsDublin, May 09, 2025 (GLOBE NEWSWIRE) -- ...

Trilobio, the Company building the fully automated robotic lab-in-a-box for biologists, today announced it has raised $8 ...

TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment (TME), ...

BERLIN--(BUSINESS WIRE)--Regulatory News: TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment of cancer by ...

Sandoz's antitrust suit against Amgen, the FDA’s interchangeability designation for Celltrion’s adalimumab biosimilar, and the inclusion of an ustekinumab biosimilar in Costco’s prescription program ...

The pharmaceutical industry has a crucial role in modern healthcare, but it also has a significant environmental footprint. From large-scale solvent use and carbon emissions to water pollution and ...

Bank of America Securities analyst Tazeen Ahmad reiterated a Buy rating on Ascendis Pharma (ASND – Research Report) today and set a price target of $192.00. Discover outperforming stocks and ...

Facilitating the amounts received from this agreement with Mayne Pharma, Sol-Gel will concentrate on the clinical and commercial development of its most advanced innovative product, SGT-610, a ...

Scotiabank initiated coverage of UroGen Pharma (URGN) with an Outperform rating and $23 price target The company is developing a novel treatment for nonmuscle invasive bladder cancer, which the fi ...

NAPLES, Fla. and CAMBRIDGE, United Kingdom, April 16, 2025 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) ("Conduit Pharmaceuticals" or "Conduit" or the "Company") today announced key ...

HERZLIYA, Israel and CALGARY, AB, April 15, 2025 /PRNewswire/ -- Innocan Pharma Corporation (the "Company") (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) is pleased to announce that it has closed its ...